Skip to content

Fully Covered Self-expandable Metal Stents (FCMS) in Benign Biliary Strictures

Temporary Placement of Fully Covered Self-expandable Metal Stents in Benign Biliary Strictures

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02105181
Enrollment
92
Registered
2014-04-07
Start date
2007-03-31
Completion date
2014-03-31
Last updated
2014-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biliary Stricture

Keywords

benign biliary stricture, anastomotic biliary stricture after liver transplantation, chronic pancreatitis, biliary surgical procedure, fully covered metal stent

Brief summary

Endoscopic treatment of benign biliary strictures can be challenging. Balloon dilation and/or plastic stent placement are currently the most popular techniques. Partially covered self-expandable metallic stents have also shown to be effective but can be difficult to remove. A novel fully covered metallic stent has recently been developed. The aim of this study was to prospectively evaluate the placement of fully covered self-expandable metallic stents (FCSEMS) in this setting.

Detailed description

After inclusion, an endoscopic procedure (ERCP) was performed in all patients in order to place a FCMS across the benign biliary stricture. The FCMS was left in place for 6 months and then extracted during a second ERCP procedure. An opacification was performed to assess the efficacy of stenting. Patients were followed up during one year after FCMS extraction.

Interventions

DEVICEPlacement of a FCMS in the biliary tract of the patients

During an ERCP procedure, a fully covered biliary metal stent (FCMS) is placed across a benign biliary stricture

Sponsors

Société Française d'Endoscopie Digestive
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* a history of liver transplantation, chronic pancreatitis or biliary surgery * impairment of liver function tests such as elevated liver enzymes and/or cholestasis * a biliary stricture associated with ductal dilation detected by US, CT or MRI, with a minimum distance of 2cm between the upper stricture's edge and the lower limit of the main biliary confluence or liver hilum .

Exclusion criteria

* an uncertainty about the benign nature of the stricture * an intra-hepatic cholangitis and/ or a stricture extending beyond the hilum

Design outcomes

Primary

MeasureTime frameDescription
Initial success rate of temporary FCMS placement6 monthsAbsence of biliary stricture or as an attenuated stricture on cholangiogram after removal of FCMS

Secondary

MeasureTime frameDescription
Final success18 monthsAbsence of biliary stricture or the presence of an attenuated stricture and normal liver function tests at the end of follow up.
Stricture recurrence18 monthsBoth clinically and ERCP-documented recurrence of stricture after an initial success.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026